Vetoquinol SA

Common Name
Vetoquinol
Country
France
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2,437
Ticker
VETO
Exchange
EURONEXT
Description
Vetoquinol S.A. is a leading pharmaceutical company specializing in veterinary medicine and animal health. Operating primarily within the veterinary pharmaceutical sector, Vetoquinol develops, manufac...

Vetoquinol's GHG Emissions Data Preview

In 2024, Vetoquinol completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Vetoquinol has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Vetoquinol’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Vetoquinol’s data sources below and access millions more through our Disclosure Search.

a. Vetoquinol's Universal Registration Document (URD) 2024
a. Vetoquinol's Universal Registration Document (URD) 2024

Insights into Vetoquinol's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Vetoquinol amounted to 9,217 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Vetoquinol decreased by 3.84%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

Vetoquinol's Scope 1 Emissions Over Time

2023202402 k4 k6 k8 ktCO2e-1%
  • Total Scope 1
  • Year-over-Year Change

What are Vetoquinol's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Vetoquinol were 7,159 metric tons of CO₂ equivalent (tCO₂e). a

Compared to the previous year (2023), Vetoquinol's Scope 1 emissions decreased by 1.47%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a

What are Vetoquinol's Scope 2 emissions?

In 2024, Vetoquinol reported Scope 2 greenhouse gas (GHG) emissions of 2,058 tCO₂e without specifying the calculation method. a

Has Vetoquinol reduced its Scope 2 emissions over time?

Compared to the previous year (2023), Vetoquinol's Scope 2 emissions (Unspecified Calculation Method) fell by 11.25% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption. a

What methodology does Vetoquinol use for Scope 2 reporting?

In 2024, Vetoquinol reported its Scope 2 emissions using an unspecified methodology. a

Vetoquinol's Scope 2 Emissions Over Time

2023202406001.2 k1.8 k2.4 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Vetoquinol’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Vetoquinol reported Scope 1 greenhouse gas (GHG) emissions of 7,159 tCO₂e and total revenues of USD 561 millions. This translates into an emissions intensity of 12.76 tCO₂e per millions USD. a

Vetoquinol's Scope 1 Emissions Intensity Compared to Peers

2002,00010,000100,000500,000Scope 1 Emissions (tCO2e)1005001,0002,00010,000Revenues (Millions of USD)CCNJCCCR Double-CraneYear: 2023Scope 1: 51,608 tCO2eRevenue: $M 1,438Scope 1 Intensity: 35.88 tCO2e/$MAlmirallYear: 2023Scope 1: 6,318 tCO2eRevenue: $M 990Scope 1 Intensity: 6.38 tCO2e/$MLuye Pharma GroupYear: 2023Scope 1: 10,755 tCO2eRevenue: $M 945Scope 1 Intensity: 11.38 tCO2e/$MHisamitsu PharmaceuticalYear: 2022Scope 1: 7,862 tCO2eRevenue: $M 1,040Scope 1 Intensity: 7.56 tCO2e/$MLivzon Pharmaceutical GroupYear: 2024Scope 1: 194,441 tCO2eRevenue: $M 1,619Scope 1 Intensity: 120.13 tCO2e/$MSawai Group HoldingsYear: 2023Scope 1: 19,500 tCO2eRevenue: $M 1,229Scope 1 Intensity: 15.87 tCO2e/$MCCChangchun High-TechYear: 2023Scope 1: 61,590 tCO2eRevenue: $M 2,050Scope 1 Intensity: 30.05 tCO2e/$MSiegfried HoldingYear: 2024Scope 1: 59,171 tCO2eRevenue: $M 1,430Scope 1 Intensity: 41.39 tCO2e/$MMankind PharmaYear: 2025Scope 1: 6,538 tCO2eRevenue: $M 1,429Scope 1 Intensity: 4.58 tCO2e/$MAlembic PharmaceuticalsYear: 2025Scope 1: 80,278 tCO2eRevenue: $M 765Scope 1 Intensity: 104.88 tCO2e/$MFagronYear: 2023Scope 1: 4,218 tCO2eRevenue: $M 844Scope 1 Intensity: 4.99 tCO2e/$MPrestige Consumer HealthcareYear: 2021Scope 1: 1,304 tCO2eRevenue: $M 943Scope 1 Intensity: 1.38 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MEvotecYear: 2024Scope 1: 13,756 tCO2eRevenue: $M 829Scope 1 Intensity: 16.59 tCO2e/$MBoironYear: 2024Scope 1: 4,720 tCO2eRevenue: $M 507Scope 1 Intensity: 9.30 tCO2e/$MTsumura & CoYear: 2021Scope 1: 39,385 tCO2eRevenue: $M 1,055Scope 1 Intensity: 37.32 tCO2e/$MNNNippon ShinyakuYear: 2023Scope 1: 4,366 tCO2eRevenue: $M 1,082Scope 1 Intensity: 4.03 tCO2e/$MEuroapiYear: 2024Scope 1: 60,846 tCO2eRevenue: $M 957Scope 1 Intensity: 63.61 tCO2e/$MIpsenYear: 2024Scope 1: 9,932 tCO2eRevenue: $M 3,720Scope 1 Intensity: 2.67 tCO2e/$MHepalinkYear: 2024Scope 1: 18,284 tCO2eRevenue: $M 724Scope 1 Intensity: 25.27 tCO2e/$MPiramal PharmaYear: 2025Scope 1: 61,351 tCO2eRevenue: $M 1,061Scope 1 Intensity: 57.85 tCO2e/$MJJJubilant PharmovaYear: 2025Scope 1: 10,084 tCO2eRevenue: $M 842Scope 1 Intensity: 11.98 tCO2e/$MChina Medical System HoldingsYear: 2023Scope 1: 1,628 tCO2eRevenue: $M 1,233Scope 1 Intensity: 1.32 tCO2e/$MHyperaYear: 2023Scope 1: 28,386 tCO2eRevenue: $M 1,632Scope 1 Intensity: 17.40 tCO2e/$MVetoquinolYear: 2024Scope 1: 7,159 tCO2eRevenue: $M 561Scope 1 Intensity: 12.76 tCO2e/$M

How does Vetoquinol's GHG emissions intensity compare to its peers?

In 2024, Vetoquinol reported a Scope 1 emissions intensity of 12.76 tCO₂e per millions USD. Compared to the peer group median of 16.23 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Vetoquinol rank on GHG emissions intensity within its industry?

In 2024, Vetoquinol ranked 12 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Vetoquinol is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to Vetoquinol's GHG Emissions Dataset?
Sign Up